Northrop Grumman Corporation (NOC) Guidance & Earnings Results

On 2026-10-20 Northrop Grumman Corporation raised guidance: "FY2027 outlook: Segment operating income increased by $65M at midpoint; MTM-adjusted EPS increased by $0.70 at midpoint. Q3 FY2027 revenue guidance $514-516M; FY2027 revenue $2.043-2.047B; Non-GAAP operating margin 21%;…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

NOCNorthrop Grumman CorporationFollow NOC — free

Aerospace & Defense · Industrials

—

Price chart with a free account

Market cap: 78.3B
P/E TTM: 17.4
Dividend yield: 1.7%
52-week: —
Next earnings: 25 Jan, in 93 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
20 Oct 26	Raised	FY2027 outlook: Segment operating income increased by $65M at midpoint; MTM-adjusted EPS increased by $0.70 at midpoint. Q3 FY2027 revenue guidance $514-516M; FY2027 revenue $2.043-2.047B; Non-GAAP operating margin 21%; Non-GAAP diluted EPS $0.76-0.78. · full year
21 Jul 26	Raised	FY26 sales raised to $43.75-44.25B from $43.5-44.0B; FY26 MTM-adjusted EPS raised to $28.60-29.10 from $27.40-27.90; operating income and adjusted free cash flow reaffirmed · full year
27 Jan 26	Raised	Mid-single digit sales growth for 2026
21 Oct 25	Raised	EPS guidance raised by $0.65 to $25.65-$26.05 · full year

Northrop Grumman Corporation — questions

What guidance did Northrop Grumman Corporation give?: On 2026-10-20: "FY2027 outlook: Segment operating income increased by $65M at midpoint; MTM-adjusted EPS increased by $0.70 at midpoint. Q3 FY2027 revenue guidance $514-516M; FY2027 revenue $2.043-2.047B; Non-GAAP operating margin 21%; Non-GAAP diluted EPS $0.76-0.78."
When does Northrop Grumman Corporation report earnings?: Northrop Grumman Corporation's next earnings report is expected on 2027-01-25.

Every figure on this page comes from Northrop Grumman Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.